WGQ-22225-34527
3 vaccinations
4 coded responses
36 check-ins
3 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 917 / CA
- Registered
- 2022-07-14
- Relationship
- Child or adolescent in my care
- Guardian
- H29-30019-87594
- Race
- Black or African American
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-07-13
Dose 1 — Pfizer-BioNTech
-
2022-07-14
Registered in v-safe
- 2022-07-14
- 2022-07-15
- 2022-07-16
- 2022-07-17
- 2022-07-18
- 2022-07-19
- 2022-07-20
- 2022-07-27
-
2022-08-03
Survey response — day 21, dose 1, under 3MedDRA: Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Fever between 101-103.8 for 3/4 daysMedDRA releases: 2024-11 · check-in free text available
-
2022-08-03
Report sent to call center — day 21, dose 1, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-08-04
- 2022-08-12
-
2022-08-15
Dose 2 — Pfizer-BioNTechCo-administered: Tetanus
- 2022-08-15
- 2022-08-16
- 2022-08-17
- 2022-08-18
- 2022-08-19
- 2022-08-20
- 2022-08-21
- 2022-08-22
- 2022-08-29
- 2022-09-05
-
2022-09-14
Survey response — day 28, dose 2, under 3MedDRA: Nasopharyngitis — Feeling: FairFree text: ColdMedDRA releases: 2024-11 · check-in free text available
- 2022-09-19
- 2022-09-26
-
2022-10-17
Dose 3 — Pfizer-BioNTech
- 2022-10-18
- 2022-10-19
- 2022-10-20
- 2022-10-21
- 2022-10-22
- 2022-10-23
- 2022-10-24
- 2022-10-31
-
2022-11-07
Survey response — day 21, dose 3, under 3MedDRA: Cough, Respiratory tract congestion — Feeling: FairFree text: Congestion and coughMedDRA releases: 2024-11 · check-in free text available
- 2022-11-14
- 2022-11-28
- 2023-01-16
-
2023-04-17
Survey response — 6 months, dose 3, under 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-13 | Pfizer-BioNTech | No |
| 2 | 2022-08-15 | Pfizer-BioNTech | Tetanus |
| 3 | 2022-10-17 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: Fever between 101-103.8 for 3/4 days
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Cold
Release 12 (Under 3) — day 21, dose 3, under 3
Symptoms: Congestion and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release